Predictive Biosciences Presents Novel Multi-Analyte Approach to Diagnostic Assay Development at Annual Meeting of the Society of Urologic Oncology (SUO)  
12/2/2009 9:35:35 AM

LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences today announced that Company scientists will be presenting a novel multi-analyte approach to the development of a non-invasive, urine-biomarker based diagnostic assay during the 10th Annual Meeting of the Society of Urologic Oncology (SUO). The research was done under collaboration agreements with Lahey Clinic Medical Center and Mayo Clinic. This pioneering scientific research represents the first example of protein and DNA biomarkers being combined into one assay to optimize performance. The SUO meeting is being held December 2-4, 2009 at the Natcher Conference Center of the National Institutes of Health (NIH) in Bethesda, Maryland.